Sunday, 19 November 2017

Patient Handling Equipment Market to see growth of 11% from 2017 to 2024

The research report “Patient Handling Equipment Market Size By Product (Wheelchairs and Scooters, Medical Beds, Bathroom Safety Supplies, Mechanical and Transfer Equipment, Ambulatory Aids, Others), By Application (Acute and Critical Care, Long Term Care, Mobility Assistance, Fall Prevention, and Others), By End-Use (Hospitals, Home Care Settings, Elderly Care Facilities, and Others) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Poland, China, India, Japan, Malaysia, Thailand, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024”, the overall patient handling equipment industry, as claimed by Global Market Insights, Inc., will exceed a valuation of USD 23 billion by 2024. The figure is reportedly more than double the market valuation of USD 9.8 billion attained in 2016.

Over the recent years, patient handling equipment market has observed a remarkable push, inherently influenced by the unprecedented advancements in medical devices business space. A transformational change has been observed in the healthcare fraternity with regards to value chain, from volume to outcome-based, patient centric approach.  The advent of new technologies, presence of strong regulatory framework, and subsequent emergence of intense competitive arena has brought forth a slew of complexities for patient handling equipment industry players.  Amidst the fierce share battle, product innovation is claimed to be one of the major growth strategies defining the sustainability quotient of the industry.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/2142

Citing a recent instance, HoverTech International, a leading giant in patient handling equipment market has recently extended its product line of highly breathable HoverMatt Single-Patient Use, specifically designed for pressure injury prevention. Reportedly, this advanced fabric technology infused air transfer mattresses protect patient skin by minimizing moisture buildup and heat transfer. Allegedly, with HoverMatt SPU, the caregivers can very smoothly turn, transfer, and position patients without much straining or lifting, given the fact there is a cushion of air beneath the inflated device which claims to reduce the pressure required to move the patient by almost 80% -90%. Experts have been already raving about the new product claiming that it to disrupt the conventional patient handling equipment industry.

Speaking along the similar lines, mobility assistance, unquestionably, is one of the lucrative application arenas of patient handling equipment market. The growing percentage of the geriatric and disabled population, who are constantly in need of walking assistance such as wheelchairs, crutches, is bound to considerably boost the market demand in the coming years. As per a report put forth by Center for Disease Control and Prevention, in U.S., almost one out of five adults are challenged with a physical disability. The study further depicted that the most common type of functional disability is mobility limitation- which is reported to be found in almost one in eight adults.

Browse key industry insights spread across 125 pages with 102 market data tables & 10 figures & charts from this 2017 report Patient Handling Equipment Market in detail along with the table of contents at:


The shocking prevalence of mobility disorder has prompted manufacturers to come up with advanced systems, which by extension is creating lucrative growth avenues for patient handling equipment industry. As per estimates, mobility assistance sector procured a major chunk of the overall patient handling equipment market share in 2016. In tandem with the technological advancements, favorable reimbursement policies for these equipments would complement the business growth in coming years.

One of the major reasons for U.S. to become the favorite spot for patient handling equipment market investors can be quite comprehended from the aforementioned statistic with regards to mobility disability. Add to this, the nation has been rigorously participating in patient handling program that constitutes minimal lift policy. The University of Iowa Hospitals and Clinics, for instance, has implemented a safe patient handling program, resulting in reducing the workers’ compensation cost as well as recovering the initial investment on equipment.  Considering the efforts that are being continuously undertaken by the U.S. government to reduce the equipment cost, U.S. patient handling equipment market is expected to witness a healthy growth over 2017-2024.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2142

However, one of the major constraints that can hamper the growth of this business space over the ensuing years is the lack of proper training provision for the nursing staffs. Companies, nonetheless, have been increasingly undertaking significant initiatives such as patient handling program to combat the challenge. Driven by the increasing takeover of technology in equipment design, in tandem with its diversified application matrix, patient handling equipment industry is sure to gain remarkable proceeds in the coming years.

Browse Related Reports:

Smart Medical Devices Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, Japan, China, India, Brazil, Mexico, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Thursday, 16 November 2017

Global Vaccines Market to witness growth of 9% CAGR from 2017 to 2024

The research report “Global Vaccines Market Size By Age Group (Pediatric, Adult), By Technology (Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant,), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), Regional Outlook (U.S., Canada, Germany, UK, Spain, Russia, Italy, France, China, Japan, India, Indonesia, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Qatar, Egypt), Technology Development, Competitive Landscape & Forecast, 2017 – 2024” by Global Market Insights, Inc. says, Global Vaccines Market size is set to exceed USD 65 billion by 2024.

Introduction of innovative technologies in vaccination, rising government support for product development will stimulate global vaccines market growth over the coming years. Growing awareness towards preventive vaccination in pediatric and increasing adoption of therapeutic vaccines in cancer treatment will fuel industry growth.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/2186

Increasing disease prevalence in underdeveloped countries coupled with growing incidence of cancer & HIV will serve as high impact rendering factor for the business growth. High cost and inadequate reimbursement coverage for vaccines will hamper industry expansion. Moreover, stringent government regulations for product approval will further restrain business growth.

Pediatric will grow at a significant rate over the forecast period owing to CDC recommendation for immunization schedule to protect children and infants before getting exposed to potentially life-threatening diseases.

Attenuated vaccines will grow at a substantial rate over the forecast period pertaining to factors such as robust antibody and cellular responses, and frequently deliberate lifelong immunity with only one or two doses.

Browse key industry insights spread across 140 pages with 108 market data tables & 9 figures & charts from this 2017 report Vaccines Market in detail along with the table of contents at:


Influenza will witness considerable growth due to growing incidence, mounting number of disease-causing microbes (pathogens) and rising awareness in emerging economies towards disease prevention. Availability of vaccines at affordable prices in hospitals and clinics will augment the segment growth.

U.S. vaccines market will witness significant growth over the forecast period pertaining to enormous impact of immunization on improving health of children and protecting them with vaccines due to epidemics of preventable diseases like mumps, pertussis, and measles.

India will witness lucrative growth due to improved efficiency of immunization programs and technological advancements in vaccine storage and transport. Rising per capita income, improved healthcare infrastructure and growing healthcare expenditure will promote business growth.

China vaccines market will grow at a substantial rate owing to rising disposable income, rapid economic growth, rising number of unvaccinated migrant workers, and delivery of efficient healthcare services.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2186

Brazil vaccines market will growth at a considerable rate over the coming years. Availability of vaccines at low cost and rising initiatives by Brazilian government to improve vaccination coverage will stimulate steady business expansion.

Some of the companies operating in industry are Abbott, AstraZeneca, Astellas Pharma, Bristol-Myers Squibb, CSL, Emergent BioSolutions, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Novavax, Pfizer and Sanofi Pasteur.

New product launches and expansion of existing product portfolio will mainly drive the business growth. Major industry participants will endeavor to fortify their market position by adopting these strategies.

Browse Related Reports:

Preventive and Therapeutic Vaccine Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Russia, China, India, Japan, Malaysia, Thailand, Indonesia, Australia, Brazil, Saudi Arabia, UAE, South Africa), Application Growth Potential, Competitive Market Growth & Forecast, 2017 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:


Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Wednesday, 15 November 2017

Health Intelligent Virtual Assistant Market to grow at 31% CAGR from 2017 to 2024


Japan being a tech-oriented country, has been projected to contribute more than USD 110 million toward regional health intelligent virtual assistant market. With a rapid increase in the occurrence of strokes and hypertension among the aging population across this region, mobile assisted services such as telehealth and mobile health are gaining popularity among consumers, which will augment the regional health intelligent virtual assistant industry share.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/1823

Increasing technological revolutions such as the emergence of IoT across the globe is certain to propel the product demand. IoT has been particularly favoring health intelligent virtual assistant industry share across UK. The country is witnessing the utilization of advanced healthcare technologies to increase the speed and accuracy of medical care operations. On that note, UK health intelligent virtual assistant market is slated to collect considerable revenue by the end of 2024. The implementation of favorable government norms will also impel the regional growth.

Speech recognition, one of the most foremost technologies, led the overall health intelligent virtual assistant industry by covering a share of more than 60% in 2015 and will register an annual growth rate of above 32% over the coming seven years. This technology is gaining popularity among the consumers owing to the deployment of smartphones. The implementation of this technology in HER will undeniably aid physicians to improve their working efficiency and productivity.

Browse key industry insights spread across 105 pages with 52 market data tables & 8 figures & charts from this 2017 report Health Intelligent Virtual Assistant Market in detail along with the table of contents at:


Text-to-speech is another lucrative technology segment of health intelligent virtual assistant market that is forecast to generate a revenue of more than USD 460 million by 2024 with a CAGR of above 30% over the years ahead. Cost effectiveness pertaining to the quality of the speech along with effective and efficient medical communication will augment the industry growth. Payers have been mainly using this technology to offer best services to the customers. In this regard, health intelligent virtual assistant market share from payers is slated to exhibit an annual growth rate of more than 30% over 2017 to 2024. Payers have also been making heavy investments to develop healthcare infrastructure, which will help to protect the patient’s data and enhance interoperability.

U.S. dominated North America health intelligent virtual assistant market by accounting for over 90% of revenue contribution in 2016 and will exhibit considerable annual growth rate over the years ahead. Growing adoption of tablets and smart phones have led to the escalating usage of mobile based healthcare services. In addition, the growing emergence of new technological developments will also enhance the industry growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1823

In order to bring about an increase in the operational efficiency and deliver effective services to consumers, many of the hospitals have been deploying these virtual assistants on a large scale. Physicians have also been using this product to tackle emergency cases. On that note, health intelligent virtual assistant market size from providers will collect a revenue of USD 820 million by 2024, having held a substantial portion of the revenue share in 2016.

The key players in health intelligent virtual assistant market are Nuance Communications, eGain Communications Pvt Ltd., Next IT Corp., CodeBaby Corp., Google, Inc., Microsoft Corporation, and True Image Interactive.

Browse Related Reports:

Healthcare Artificial Intelligence Market Size By Application (Medical Imaging & Diagnosis, Drug Discovery, Therapy Planning, Hospital Workflow), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, India, Japan, Australia, Brazil, Mexico, South Africa), Growth Potential, Competitive Market Share & Forecast, 2017 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Tuesday, 14 November 2017

Contraceptives Market to witness more than 6.8% CAGR from 2017 to 2024

Contraceptives Market size is set to exceed USD 35 billion by 2024; according to a new research report by Global Market Insights, Inc.

Rising prevalence of sexually transmitted diseases, favorable regulatory scenario in developed nations, increasing delayed pregnancy trend and high unmet contraceptive needs in developing economies will serve as high impact rendering factors for the contraceptives market growth.

Increasing government initiatives to raise awareness to prevent unintended pregnancies and growing population base creating massive demand for contraceptives will stimulate business growth over the coming years. Growing late pregnancy choice, rising burden of HIV epidemic coupled with demand for reproductive health and modern contraception will propel the industry growth.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/430

Moreover, increasing use of contraceptive in under developed countries and rising awareness towards disease prevention will further boost the business size. However, growing elderly population pool, increasing infertility prevalence and several concerns pertaining to side effects may restrain adoption in emerging economies.

Oral contraceptive pills market should witness significant growth over the forecast period owing to factors such as most effective method of birth control, daily consumption resulting in reduced cramping during periods, enabling acne reduction and minimized risk of developing cervical & endometrial cancers. Growing use of injectable drugs that are injected under the skin and released in the bloodstream to prevent unwanted pregnancy and effective in preventing unwanted birth will drive the augmented demand for the drug.

Browse key industry insights spread across 110 pages with 102 market data tables & 10 figures & charts from the report Contraceptives Market in detail along with the table of contents:


Condoms segment accounted for the largest share in 2016 and will grow significantly over the forecast period. Male condoms are widely used and are considered as first line of protection worldwide. Associated advantages like ease to use, affordable cost, elevated level of protection and least side effects amongst all the other devices will drive the segment growth. Furthermore, increasing demand of IUD’s owing to high degree of effectiveness and most efficacious alternatives available in female contraceptives market will offer considerable segment growth.

U.S. contraceptives market will grow at a substantial rate over the forecast period. Increasing awareness towards contraceptives and number of advantages associated with the contraceptive methods resulting in increased usage will fuel the business growth.

Availability of the national health insurance scheme for women under the age of 18 covering UTI and emergency contraception completely, increasing use of contraceptive methods as well as advent of better methods with low side effects will propel the industry growth in Germany.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/430

Increasing occurrences of STDs, rising awareness about disease and birth control methods, improving healthcare infrastructure coupled with favorable reimbursement policies will drive the Chinese contraceptives market over the forecast period.

Rising awareness about sexually transmitted diseases and benefits delivered by contraceptive methods will boost Brazil contraceptive market over the coming years. Availability of pills and condoms in primary healthcare facilities for free in the country will fuel the industry growth in the country.

Some of the companies functioning in the contraceptives market are Actavis, Cooper Surgical, Reckitt Benckiser, Merck, Pfizer, Church & Dwight, Teva Pharmaceutical Industries, Mayer Laboratories and The Female Health Company.

New product launches, increasing R&D investments, mergers and acquisition, geographical expansion will fuel the business growth. Leading business players will endeavor to reinforce their position in this competitive market by implementation of these strategies.

Browse Related Reports:

HIV Diagnostics Market Size By Product [Antibody Tests (HIV-1 Screening, ELISA/EIA, Home Access Dried Blood Spot, Rapid Test, HIV-1 Confirmatory Steps, Western Blot, Indirect Immunoflorescent Antibody Assay (IIFA), Line Immunoassay , RadioImmuno Precipitation Assay (RIPA), HIV-2 & Group O Test, Blood Antibody, Dried Blood Spot), Viral Identification Assay (p24 Antigen, Qualitative PCR, Viral Culture), CD4, Viral Load, Early Infant Diagnosis], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, South Africa, Brazil), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Monday, 13 November 2017

Antidiabetics Market share to grow at 10.5% CAGR from 2016 to 2024

Inherently propelled by a stringent regulatory framework, antidiabetics market is strongly characterized by the legalized norms implemented by authorized bodies such as the European CE and the FDA. Having undertaken the crucial responsibility of regulating the commercialization of antidiabetics in clinical trials, these organizations continue to strive hard to approve drugs post their testing with utmost caution and precision, which is a prime factor driving the growth of antidiabetics industry. For instance, recently, the U.S. Food and Drug Administration approved the Bydureon BCise (exenatide extended-release) injectable suspension manufactured by AstraZeneca.

Apparently, this drug is an all-new formulation of Bydureon that is available as a single-dose autoinjector device for adults suffering from Type II diabetes. The Bydureon BCise apparently underwent two clinical trials prior to obtaining the approval, thus validating the fact that antidiabetics market outlook is strictly defined by a regulatory frame of reference.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/504

With the exponentially growing population and the prevalence of a sedentary lifestyle, a significant rise in the patient pool suffering from diabetes has been observed, which is likely to spur global antidiabetics market share. The WHO estimates that diabetes would be among the leading causes of death by 2030, which would severely strain the overall healthcare fraternity. The rising number of diabetic cases have prompted the governments across various geographies to take steps toward promoting awareness regarding this disorder. For instance, the ‘Diabetes UK’ is slated to launch one of the biggest campaigns to encourage consciousness regarding Type II diabetes.

The program will also make people aware of the harmful consequences of developing diabetes, encourage them to get screened regularly, and provide other related details. The prevalence of campaigns and awareness programs such as the aforementioned are certain to bring about a positive influence on antidiabetics market size, which was pegged at USD 49.5 billion in 2016.

Browse key industry insights spread across 130 pages with 55 market data tables & 8 figures & charts from the report Antidiabetics Market in detail along with the table of contents:


In consequence to the unmet medical requirements of the healthcare fraternity and the rapid increase in the diabetic patient base, antidiabetics industry players have been concentrating on increasing their funding on research & development activities with an aim to launch novel insulin products that will efficiently treat this persistent sugar disorder. Major companies such as Sanofi Aventis, Eli Lilly, and Novo Nordisk presently predominate antidiabetic market share, pertaining to their popular brand value, wide range of products, and increased R&D investments. Many antidiabetics products that are currently in the pipeline to be commercialized are manufactured by these companies. In addition, global antidiabetics industry involves the participation of other generic manufacturers such as Pfizer, Oramed Pharmaceuticals, Inc., Takeda Pharmaceuticals, Boehringer Ingelheim, and Merck & Co. Inc.

An insight into APAC antidiabetics market trends:

The Asia Pacific region has been forecast to emerge as the potential hotbed for investors emptying their coffers in antidiabetics industry. This estimation may be attributed to the fact that the region has been witnessing a tremendous surge in the patient pool suffering from diabetes, especially in India and China. As per reliable statistics, close to nearly two decades earlier, in 2000, India stood at the top of the pyramid representing diabetes sufferers, with more than 31.7 million of its populace afflicted by the disease, while China stood at the second place with 20.8 million diabetic patients in tow. It has been forecast that by 2030, this number would increase up to 79.4 million patients in India and 42.3 million individuals in China. The estimates stand to validate that these countries would prove to be lucrative grounds for companies partaking in antidiabetics market share, as they would be able to bring forth a range of medications for treating the affliction in these regions.

Another emerging region in this continent has been touted to be Japan. The country, with its incredible healthcare infrastructure, rising penetration of technologically innovative insulin drugs, and the growing prevalence of diabetes among the geriatric populace, will serve to be a profitable growth avenue for APAC antidiabetics market.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/504

Regulatory and governmental bodies across the globe have been striving to increase public awareness regarding diabetes, which most certainly would provide an impetus to antidiabetics market. For instance, the National Institute of Diabetes and Digestive and Kidney Diseases has undertaken several education campaigns such as ‘Small Steps, Big Rewards’, ‘Control your Diabetes for Life’, etc., to increase the importance of diabetic screening, diagnosis, and treatment. Not far behind in the list of organizations is the American Diabetes Association, that has also launched several awareness programs regarding diabetes, which would help carve out a lucrative growth path for global antidiabetics market over the years ahead. In addition, the International Diabetes Federation, along with its member associations celebrate the 14th of November as ‘World Diabetes Day’, utilizing the 24-hour span to initiate awareness campaigns and other related programs. With a strong regulatory framework and governmental support in place, not to mention, the pivotal developments underlining the medical research and healthcare verticals, it is forecast that antidiabetics industry will chart a profitable growth curve over the coming seven years, with an estimated valuation of USD 110 billion by 2024.


Precision Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter